Document Detail


Conditioned blood reperfusion during angioplasty (CoBRA) treatment of acute myocardial infarction.
MedLine Citation:
PMID:  11334205     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Acute myocardial infarct (MI) results in ischemia distal to lesions which puts heart muscle at risk for reperfusion injury (RI). Neutrophils, platelets and complement are putative mediators of RI. Recent advances in filtration technology provide integrated neutrophil and platelet removal together with complement-attenuating properties in a single blood-conditioning device. The present study characterizes the properties of a blood-conditioning filter and describes its clinical effect when used in conjunction with active hemoperfusion for acute MI. The filter reduces leukocytes by 99.9998 +/- 0.0002% (p<0.0001) and platelets by 99.9934 +/- 0.0069% (p<0.0001). Human plasma, derived from heparinized blood that was 'conditioned' by filtration, was studied using the Langendorff isolated rabbit heart preparation. The deposition of membrane attack complex and the resultant functional myocardial impairments [reflected in hemodynamic and biochemical measurements, including developed pressure, coronary blood flow, lymph-derived myocardial creatine kinase (CK)] are significantly attenuated by blood conditioning. Integration of the blood-conditioning filter into an active hemoperfusion system during primary percutaneous transluminal coronary angioplasty (PTCA) for acute MI (n=8) did not delay the procedure or cause any complications. Reperfusion of occluded coronary arteries with 300 cm3 of conditioned blood led to significant improvement in echocardiographic global wall motion scores (in standard deviations) following treatment (-1.64 +/- 0.18 to -1.45 +/- 0.15, p=0.02). Initial reperfusion of totally occluded coronary arteries with conditioned blood leads to acutely improved ventricular function. Collectively, these data provide a strong indication for continued investigation of conditioned blood reperfusion in angioplasty following acute MI for the long-term effect upon recovery of salvagable myocardium.
Authors:
M B Patel; K S Kilgore; G A Ortolano; C L Gryboski; M A Qureshi; P Marcovitz; K B Naylor; J L Park; B Wenz; N Gikakis; R J Freedman; B R Lucchesi; W W O'Neill
Related Documents :
12024335 - Triggers of acute coronary syndromes.
19706385 - Prevascularization of cardiac patch on the omentum improves its therapeutic outcome.
16904535 - Young adult myocardial infarction and ischemic stroke: the role of paradoxical embolism...
18001625 - Aspirin in the treatment and prevention of cardiovascular disease: current perspectives...
19577245 - Diagnostic accuracy of extended-length electrocardiogram in differentiating between ath...
3814455 - Transient shock and myocardial impairment caused by phaeochromocytoma crisis.
Publication Detail:
Type:  Clinical Trial; In Vitro; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Perfusion     Volume:  16 Suppl     ISSN:  0267-6591     ISO Abbreviation:  Perfusion     Publication Date:  2001 Mar 
Date Detail:
Created Date:  2001-05-03     Completed Date:  2002-01-14     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8700166     Medline TA:  Perfusion     Country:  England    
Other Details:
Languages:  eng     Pagination:  39-49     Citation Subset:  IM    
Affiliation:
Department of Cardiology, William Beaumont Hospital, Royal Oak, Michigan, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Angioplasty, Transluminal, Percutaneous Coronary / methods*
Animals
Complement Membrane Attack Complex / metabolism,  pharmacology
Electrocardiography
Female
Filtration / methods
Humans
Leukapheresis
Male
Middle Aged
Myocardial Infarction / blood,  physiopathology,  surgery*
Pilot Projects
Plateletpheresis
Prospective Studies
Rabbits
Reperfusion / methods*
Reperfusion Injury / etiology,  prevention & control
Stroke Volume
Ventricular Function, Left
Chemical
Reg. No./Substance:
0/Complement Membrane Attack Complex

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Timing of leukocyte filtration during cardiopulmonary bypass.
Next Document:  Leukodepletion and aprotinin improve clinical outcome after extracorporeal circulation.